Home About Us
At Kinase Insight, we pave the way for groundbreaking advancements in the realm of protein kinase exploration. With a commitment to precision and a deep understanding of the intricate world of kinase proteins, we stand at the forefront of innovation in proteomics.
If cancer is a complex puzzle, Kinase Insight strives to be the beacon of light within that puzzle. Our proprietary proteomics technology delves into the critical regulation of proteins, particularly tyrosine kinase phosphorylation, providing stable, specific, and reproducible industrial-grade functional proteomic analysis.
Our core technology focuses on the crucial regulatory proteins involved in tumorigenesis, shedding light on the driving factors with a direct and precise reflection of tumor initiation. We comprehensively understand signaling pathway activity and immune functionality, offering key solutions for precise therapeutic interventions.
Our specialized deep phosphoproteomic technology platform, complemented by in-house developed methods and a bioinformatics platform, covers total protein, total phosphorylation, and tyrosine phosphorylation. This comprehensive approach provides efficient and comprehensive solutions for drug development and patient treatment.
Underpinned by our technology, Kinase Insight has developed a cutting-edge drug discovery service platform. Collaborating with advanced equipment such as Orbitrap Exploris 480 and Q Exactive Plus, we have served numerous pharmaceutical enterprises with high-quality proteomic analysis services.
Our high-resolution, targeted quantitative platform marks the next frontier after genomics. From unraveling complexities to organized insights, this platform leads the way in precision oncology and resistance-guided therapy.
In the realm of medicinal proteomics, Kinase Insight is dedicated to being a catalyst for transformative healthcare. Our brand represents not just expertise in kinase proteins but a commitment to unlocking the dynamic potential of proteomic insights, guiding us towards a future where diseases are understood with unprecedented precision.